These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 363517)

  • 21. [Study of promutagen biotransformation in the Ames test. IV. The effect of transplanted tumors on the biotransformation of various antineoplastic agents].
    Oblapenko NG; Loknitskaia NN; Presnova ZhF; Chernov VA; Fonshteĭn LM
    Genetika; 1986 Sep; 22(9):2265-71. PubMed ID: 3533723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic activation and deactivation of mutagens and carcinogens.
    De Flora S
    Ital J Biochem; 1979; 28(2):81-103. PubMed ID: 399955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study on the mutagenic effect of some Bulgarian drugs using the Salmonella/microsome test.
    Dimitrova K; Ivanov V; Bogoeva M; Golovinsky E; Markov K
    Acta Physiol Pharmacol Bulg; 1983; 9(4):31-6. PubMed ID: 6375259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The process of promutagen biotransformation studied by the Ames test. II. The extent of the manifestation of the mutagenic action of nitrosomorpholine, diethylnitrosamine and cyclophosphane using various subfractions of rat liver homogenate].
    Loknitskaia NN; Fonshteĭn LM
    Genetika; 1985 Dec; 21(12):1932-6. PubMed ID: 4085789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Greater effectiveness of hepatocyte and liver S9 preparations from hamsters than rat preparations in activating N-nitroso compounds to metabolites mutagenic to Salmonella.
    Raineri R; Poiley JA; Andrews AW; Pienta RJ; Lijinsky W
    J Natl Cancer Inst; 1981 Nov; 67(5):1117-22. PubMed ID: 6946249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of microsomal and cytosolic fractions from rat, mouse, and hamster liver on the mutagenicity of dimethylnitrosamine in the Salmonella plate incorporation assay.
    Prival MJ; Mitchell VD
    Cancer Res; 1981 Nov; 41(11 Pt 1):4361-7. PubMed ID: 7030474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative mutagenicity of some urinary metabolites of the antitumor drug cyclophosphamide.
    Balbinder E; Reich CI; Shugarts D; Keogh J; Fibiger R; Jones T; Banks A
    Cancer Res; 1981 Jul; 41(7):2967-72. PubMed ID: 7018675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro mutagenicity assays of chemical carcinogens and related compounds with Salmonella typhimurium.
    Simmon VF
    J Natl Cancer Inst; 1979 Apr; 62(4):893-9. PubMed ID: 372657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mutagenic activity of 2,4,6-trinitrotoluene: the role of metabolizing enzymes].
    Karamova NS; Il'inskaia ON; Ivanchenko OB
    Genetika; 1994 Jul; 30(7):898-902. PubMed ID: 7958804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutagenicity of N-nitrosopiperazine derivatives in Salmonella typhimurium.
    Rao TK; Young JA; Lijinsky W; Epler JL
    Mutat Res; 1978 May; 57(2):127-34. PubMed ID: 351385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mutagenic activity of antitubercular preparations: isonicotinic acid hydrazide and its derivatives].
    Shapiro AA; Meksin VA; Abilev SK; Akin'shina LP; Fonshteĭn LM
    Tsitol Genet; 1978; 12(4):343-8. PubMed ID: 360538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unambiguous synthesis of asymmetrically substituted chlorinated benzidines, and a study of their mutagenicity in the Ames test: potent activity of 3,5,3'-trichlorobenzidine.
    Josephy PD; Williams LL
    Mutagenesis; 1987 May; 2(3):225-8. PubMed ID: 3325748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testing of some benzidine analogues for microsomal activation to bacterial mutagens.
    Garner RC
    Cancer Lett; 1975 Sep; 1(1):39-42. PubMed ID: 797441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benzidine activation in the Ames test: roles of hepatic N-acetyltransferase and other cytosolic and microsomal factors.
    Light HC; Hubert JJ; Josephy PD; Mattano SS; Weber WW
    Carcinogenesis; 1987 Jan; 8(1):139-43. PubMed ID: 3542272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutagenicity of N-nitrosomorpholine in the host-mediated assay.
    Zeiger E; Legator MS
    Mutat Res; 1971 Aug; 12(4):469-71. PubMed ID: 4938283
    [No Abstract]   [Full Text] [Related]  

  • 36. Peroxidative metabolism of benzidine derivatives by Salmonella typhimurium.
    de France BF; Josephy PD
    Chem Biol Interact; 1987; 64(1-2):193-202. PubMed ID: 2826024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the metabolic activation of benzidine by isolated rat hepatocytes.
    Brouns RM; Bos RP; Van Doorn R; Henderson PT
    Toxicology; 1982; 23(2-3):235-47. PubMed ID: 7112596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of point mutations by different chemical mechanisms in the liver microsomal assay.
    Herbold B; Buselmaier W
    Mutat Res; 1976 Apr; 40(2):73-84. PubMed ID: 778610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of nitrosomorpholine and nitrosopyrrolidine to bacterial mutagens.
    Gomez RF; Johnston M; Sinskey AJ
    Mutat Res; 1974 Jul; 24(1):5-7. PubMed ID: 4602225
    [No Abstract]   [Full Text] [Related]  

  • 40. N-nitrosomorpholine.
    IARC Monogr Eval Carcinog Risk Chem Man; 1978 May; 17():263-80. PubMed ID: 355101
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.